FDA issued a Warning Letter to Sunrise Pharmaceutical, Inc. on 1/14/2010 as a result of this inspection.
FDA investigators audited the Sunrise Pharmaceutical - Rahway, NJ, United States facility and issued inspectional observations (via FDA 483) on 17 Jul 2009.
Add To Cart
- Category: Human Drugs
- Inspection end: 17 Jul 2009
- Location: Rahway, United States
- FEI: 3004813394